Mark S. Blumenkranz Insider Trading $ADVM Adverum Biotechnologies, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark S. Blumenkranz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark S. Blumenkranz. Mark S. Blumenkranz is Director in 1Life Healthcare Inc ($ONEM) and Director in IVERIC bio, Inc. ($OPHT) and Director in Adverum Biotechnologies, Inc. ($AAVL) and Director in Presbia PLC ($LENS).
Mark S. Blumenkranz in Adverum Biotechnologies, Inc.
Trading Symbol: ADVMIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark S. Blumenkranz: Director
Holdings: 531,322 shares
Latest Transaction: Feb 17 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark S. Blumenkranz in Adverum Biotechnologies, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ONEM, ADVM, OPHT, LENS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2016 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | A | 4.80 | 11,905 | 57,144 | 11,905 | |
Feb 17 2016 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Grant | A | 0.00 | 8,333 | 0 | 531,322 | 523 K to 531.3 K (+1.59 %) |
Jun 15 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 39.97 | 1,900 | 75,939 | 522,989 | 524.9 K to 523 K (-0.36 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 39.91 | 600 | 23,948 | 524,889 | 525.5 K to 524.9 K (-0.11 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 37.35 | 200 | 7,470 | 525,489 | 525.7 K to 525.5 K (-0.04 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.20 | 7,000 | 253,402 | 525,689 | 532.7 K to 525.7 K (-1.31 %) |
Jun 11 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 35.52 | 15,300 | 543,456 | 532,689 | 548 K to 532.7 K (-2.79 %) |
Jun 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 40.08 | 5,000 | 200,414 | 547,989 | 553 K to 548 K (-0.90 %) |
May 21 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.91 | 1,000 | 36,911 | 10,531 | 11.5 K to 10.5 K (-8.67 %) |
May 21 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.91 | 1,000 | 36,911 | 10,531 | 11.5 K to 10.5 K (-8.67 %) |
May 21 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.91 | 1,000 | 36,911 | 10,531 | 11.5 K to 10.5 K (-8.67 %) |
May 18 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 36.00 | 4,525 | 162,886 | 552,989 | 557.5 K to 553 K (-0.81 %) |
May 18 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 35.36 | 17,975 | 635,666 | 557,514 | 575.5 K to 557.5 K (-3.12 %) |
May 13 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 34.94 | 715 | 24,984 | 575,489 | 576.2 K to 575.5 K (-0.12 %) |
May 12 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 34.91 | 1,785 | 62,323 | 576,204 | 578 K to 576.2 K (-0.31 %) |
May 05 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 32.37 | 20,000 | 647,306 | 577,989 | 598 K to 578 K (-3.34 %) |
Apr 23 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | A | 39.35 | 7,000 | 275,450 | 7,000 | |
Apr 23 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Grant | A | 0.00 | 2,000 | 0 | 597,989 | 596 K to 598 K (+0.34 %) |
Apr 20 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 42.04 | 200 | 8,408 | 595,989 | 596.2 K to 596 K (-0.03 %) |
Apr 20 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 41.59 | 24,800 | 1,031,345 | 596,189 | 621 K to 596.2 K (-3.99 %) |
Apr 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 39.06 | 32 | 1,250 | 11,531 | 11.6 K to 11.5 K (-0.28 %) |
Apr 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 38.59 | 968 | 37,353 | 11,563 | 12.5 K to 11.6 K (-7.72 %) |
Apr 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 39.06 | 32 | 1,250 | 11,531 | 11.6 K to 11.5 K (-0.28 %) |
Apr 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 38.59 | 968 | 37,353 | 11,563 | 12.5 K to 11.6 K (-7.72 %) |
Apr 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 39.06 | 32 | 1,250 | 11,531 | 11.6 K to 11.5 K (-0.28 %) |
Apr 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 38.59 | 968 | 37,353 | 11,563 | 12.5 K to 11.6 K (-7.72 %) |
Apr 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 39.94 | 2,500 | 99,841 | 620,989 | 623.5 K to 621 K (-0.40 %) |
Apr 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 39.06 | 726 | 28,358 | 623,489 | 624.2 K to 623.5 K (-0.12 %) |
Apr 08 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 38.59 | 21,774 | 840,202 | 624,215 | 646 K to 624.2 K (-3.37 %) |
Jan 15 2015 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Sell | S | 55.46 | 100,000 | 5,546,000 | 645,989 | 746 K to 646 K (-13.41 %) |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | C | 0.00 | 12,531 | 0 | 0 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | X | 0.00 | 4,137 | 0 | 12,531 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | X | 1.45 | 4,137 | 5,999 | 0 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | C | 0.00 | 12,531 | 0 | 0 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | X | 0.00 | 4,137 | 0 | 12,531 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | X | 1.45 | 4,137 | 5,999 | 0 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | C | 0.00 | 12,531 | 0 | 0 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | X | 0.00 | 4,137 | 0 | 12,531 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | X | 1.45 | 4,137 | 5,999 | 0 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | C | 0.00 | 20,989 | 0 | 0 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | X | 0.00 | 5,689 | 0 | 20,989 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | X | 1.45 | 5,689 | 8,249 | 0 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | X | 0.15 | 25,000 | 3,750 | 0 | |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Buy | C | 0.00 | 12,531 | 0 | 12,531 | 0 to 12.5 K |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Buy | C | 0.00 | 12,531 | 0 | 12,531 | 0 to 12.5 K |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Buy | C | 0.00 | 12,531 | 0 | 12,531 | 0 to 12.5 K |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Buy | C | 0.00 | 20,989 | 0 | 745,989 | 725 K to 746 K (+2.90 %) |
Aug 07 2014 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Buy | X | 0.15 | 25,000 | 3,750 | 725,000 | 700 K to 725 K (+3.57 %) |
Page: 1